The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bi-Specific Antibodies Therapy Market Research Report 2025
Synopsis
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
The global Bi-Specific Antibodies Therapy market was valued at US$ 3266 million in 2023 and is anticipated to reach US$ 17140 million by 2030, witnessing a CAGR of 26.4% during the forecast period 2024-2030.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bi-Specific Antibodies Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bi-Specific Antibodies Therapy.
Report Scope
The Bi-Specific Antibodies Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bi-Specific Antibodies Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bi-Specific Antibodies Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
Segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies
Segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bi-Specific Antibodies Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
The global Bi-Specific Antibodies Therapy market was valued at US$ 3266 million in 2023 and is anticipated to reach US$ 17140 million by 2030, witnessing a CAGR of 26.4% during the forecast period 2024-2030.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bi-Specific Antibodies Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bi-Specific Antibodies Therapy.
Report Scope
The Bi-Specific Antibodies Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bi-Specific Antibodies Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bi-Specific Antibodies Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
Segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies
Segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bi-Specific Antibodies Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fragment-Based Antibodies
1.2.3 IgG-Based Antibodies
1.3 Market by Application
1.3.1 Global Bi-Specific Antibodies Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Non-Cancer Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bi-Specific Antibodies Therapy Market Perspective (2019-2030)
2.2 Bi-Specific Antibodies Therapy Growth Trends by Region
2.2.1 Global Bi-Specific Antibodies Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bi-Specific Antibodies Therapy Historic Market Size by Region (2019-2024)
2.2.3 Bi-Specific Antibodies Therapy Forecasted Market Size by Region (2025-2030)
2.3 Bi-Specific Antibodies Therapy Market Dynamics
2.3.1 Bi-Specific Antibodies Therapy Industry Trends
2.3.2 Bi-Specific Antibodies Therapy Market Drivers
2.3.3 Bi-Specific Antibodies Therapy Market Challenges
2.3.4 Bi-Specific Antibodies Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bi-Specific Antibodies Therapy Players by Revenue
3.1.1 Global Top Bi-Specific Antibodies Therapy Players by Revenue (2019-2024)
3.1.2 Global Bi-Specific Antibodies Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Bi-Specific Antibodies Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bi-Specific Antibodies Therapy Revenue
3.4 Global Bi-Specific Antibodies Therapy Market Concentration Ratio
3.4.1 Global Bi-Specific Antibodies Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific Antibodies Therapy Revenue in 2023
3.5 Bi-Specific Antibodies Therapy Key Players Head office and Area Served
3.6 Key Players Bi-Specific Antibodies Therapy Product Solution and Service
3.7 Date of Enter into Bi-Specific Antibodies Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bi-Specific Antibodies Therapy Breakdown Data by Type
4.1 Global Bi-Specific Antibodies Therapy Historic Market Size by Type (2019-2024)
4.2 Global Bi-Specific Antibodies Therapy Forecasted Market Size by Type (2025-2030)
5 Bi-Specific Antibodies Therapy Breakdown Data by Application
5.1 Global Bi-Specific Antibodies Therapy Historic Market Size by Application (2019-2024)
5.2 Global Bi-Specific Antibodies Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bi-Specific Antibodies Therapy Market Size (2019-2030)
6.2 North America Bi-Specific Antibodies Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bi-Specific Antibodies Therapy Market Size by Country (2019-2024)
6.4 North America Bi-Specific Antibodies Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bi-Specific Antibodies Therapy Market Size (2019-2030)
7.2 Europe Bi-Specific Antibodies Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bi-Specific Antibodies Therapy Market Size by Country (2019-2024)
7.4 Europe Bi-Specific Antibodies Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size (2019-2030)
8.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bi-Specific Antibodies Therapy Market Size (2019-2030)
9.2 Latin America Bi-Specific Antibodies Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bi-Specific Antibodies Therapy Market Size by Country (2019-2024)
9.4 Latin America Bi-Specific Antibodies Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size (2019-2030)
10.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Bi-Specific Antibodies Therapy Introduction
11.1.4 Roche Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Bi-Specific Antibodies Therapy Introduction
11.2.4 Amgen Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Bi-Specific Antibodies Therapy Introduction
11.3.4 Sanofi Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bi-Specific Antibodies Therapy Introduction
11.4.4 Pfizer Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Introduction
11.5.4 Johnson & Johnson Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Bi-Specific Antibodies Therapy Introduction
11.6.4 AstraZeneca Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Bi-Specific Antibodies Therapy Introduction
11.7.4 AbbVie Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.7.5 AbbVie Recent Development
11.8 Lindis Biotech
11.8.1 Lindis Biotech Company Detail
11.8.2 Lindis Biotech Business Overview
11.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Introduction
11.8.4 Lindis Biotech Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.8.5 Lindis Biotech Recent Development
11.9 MacroGenics, Inc
11.9.1 MacroGenics, Inc Company Detail
11.9.2 MacroGenics, Inc Business Overview
11.9.3 MacroGenics, Inc Bi-Specific Antibodies Therapy Introduction
11.9.4 MacroGenics, Inc Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.9.5 MacroGenics, Inc Recent Development
11.10 Genmab
11.10.1 Genmab Company Detail
11.10.2 Genmab Business Overview
11.10.3 Genmab Bi-Specific Antibodies Therapy Introduction
11.10.4 Genmab Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.10.5 Genmab Recent Development
11.11 Alphamab Co. Ltd
11.11.1 Alphamab Co. Ltd Company Detail
11.11.2 Alphamab Co. Ltd Business Overview
11.11.3 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Introduction
11.11.4 Alphamab Co. Ltd Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.11.5 Alphamab Co. Ltd Recent Development
11.12 Akeso, Inc.
11.12.1 Akeso, Inc. Company Detail
11.12.2 Akeso, Inc. Business Overview
11.12.3 Akeso, Inc. Bi-Specific Antibodies Therapy Introduction
11.12.4 Akeso, Inc. Revenue in Bi-Specific Antibodies Therapy Business (2019-2024)
11.12.5 Akeso, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
